Clayton Partners LLC Sells 817 Shares of National Health Investors, Inc. (NYSE:NHI)

Clayton Partners LLC lessened its holdings in shares of National Health Investors, Inc. (NYSE:NHI) by 1.2% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 69,062 shares of the real estate investment trust’s stock after selling 817 shares during the quarter. National Health Investors accounts for about 3.8% of Clayton Partners LLC’s investment portfolio, making the stock its 7th largest holding. Clayton Partners LLC owned approximately 0.16% of National Health Investors worth $4,678,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of NHI. Norges Bank acquired a new position in shares of National Health Investors during the fourth quarter worth about $25,448,000. Land & Buildings Investment Management LLC raised its holdings in shares of National Health Investors by 81.8% during the 4th quarter. Land & Buildings Investment Management LLC now owns 412,052 shares of the real estate investment trust’s stock valued at $23,013,000 after buying an additional 185,377 shares during the period. Sound Income Strategies LLC lifted its position in National Health Investors by 21,963.3% during the 2nd quarter. Sound Income Strategies LLC now owns 153,119 shares of the real estate investment trust’s stock worth $10,371,000 after acquiring an additional 152,425 shares in the last quarter. Lee Danner & Bass Inc. purchased a new position in National Health Investors in the 2nd quarter worth approximately $5,089,000. Finally, Sumitomo Mitsui Trust Holdings Inc. grew its position in National Health Investors by 16.0% in the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 472,959 shares of the real estate investment trust’s stock valued at $32,034,000 after acquiring an additional 65,104 shares in the last quarter. Hedge funds and other institutional investors own 62.51% of the company’s stock.

National Health Investors Stock Down 0.2 %

NYSE:NHI opened at $83.21 on Friday. The company has a debt-to-equity ratio of 0.91, a quick ratio of 10.27 and a current ratio of 10.27. The company has a market capitalization of $3.61 billion, a price-to-earnings ratio of 27.28, a price-to-earnings-growth ratio of 8.67 and a beta of 1.03. National Health Investors, Inc. has a one year low of $48.51 and a one year high of $86.13. The stock has a 50-day simple moving average of $77.68 and a 200 day simple moving average of $68.75.

National Health Investors (NYSE:NHI) last issued its earnings results on Tuesday, August 6th. The real estate investment trust reported $0.81 EPS for the quarter, missing the consensus estimate of $1.10 by ($0.29). National Health Investors had a return on equity of 10.11% and a net margin of 39.11%. The firm had revenue of $84.97 million during the quarter, compared to analyst estimates of $64.95 million. During the same quarter in the previous year, the business posted $1.06 EPS. National Health Investors’s revenue was up 9.1% compared to the same quarter last year. Sell-side analysts predict that National Health Investors, Inc. will post 4.55 EPS for the current fiscal year.

National Health Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Investors of record on Friday, September 27th will be given a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.33%. The ex-dividend date is Friday, September 27th. National Health Investors’s dividend payout ratio is presently 118.03%.

Analyst Ratings Changes

Several research analysts have recently weighed in on NHI shares. StockNews.com upgraded shares of National Health Investors from a “hold” rating to a “buy” rating in a research note on Thursday, August 8th. Truist Financial boosted their price target on National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a research note on Friday, August 30th. Finally, Wells Fargo & Company lifted their price objective on National Health Investors from $63.00 to $69.00 and gave the stock an “overweight” rating in a report on Thursday, May 30th. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $65.43.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.